Total: 2198

    Spasticity in under 19s: management

    This guideline covers managing spasticity and co-existing motor disorders and their early musculoskeletal complications in children and young people (from birth up to their 19th birthday) with non-progressive brain disorders. It aims to reduce variation in practice and help healthcare professionals to se...

    Clinical Practice Guidelines From the AABB: Red Blood Cell Transfusion Thresholds and Storage

    JAMA; 316 (19), 2016
    "IMPORTANCE: More than 100 million units of blood are collected worldwide each year, yet the indication for red blood cell (RBC) transfusion and the optimal length of RBC storage prior to transfusion are uncertain. OBJECTIVE: To provide recommendations for the target hemoglobin level for RBC transfusion...

    Physical health of people in prison

    This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines....

    Management of Acute and Recurrent Gout: A Clinical Practice Guideline From the American College of Physicians

    Ann. intern. med; 166 (1), 2016
    DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the management of gout. METHODS: Using the ACP grading system, the committee based these recommendations on a systematic review of randomized, controlled trials; ...

    Diabetes Technology-Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline

    J. clin. endocrinol. metab; 101 (11), 2016
    "OBJECTIVE: To formulate clinical practice guidelines for the use of continuous glucose monitoring and continuous subcutaneous insulin infusion in adults with diabetes. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of seven experts, a methodologist, and a medical write...

    Clinical Practice Guidelines for Sustained Neuromuscular Blockade in the Adult Critically Ill Patient

    Crit. care med; 44 (11), 2016
    "OBJECTIVE: To update the 2002 version of ""Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient."" DESIGN: A Task Force comprising 17 members of the Society of Critical Medicine with particular expertise in the use of neuromuscular-blocking agents; a Gra...

    Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline

    J. clin. endocrinol. metab; 101 (11), 2016
    "OBJECTIVE: To formulate clinical practice guidelines for hormonal replacement in hypopituitarism in adults. PARTICIPANTS: The participants include an Endocrine Society-appointed Task Force of six experts, a methodologist, and a medical writer. The American Association for Clinical Chemistry, the Pituit...

    Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society

    J Antimicrob Chemother; 71 (11), 2016
    BACKGROUND: Guideline development should be based on the quality of evidence, balance of benefits and harms, economic evaluation and patients' views and preferences. Therefore, these factors were considered in the development of a new guideline for therapeutic drug monitoring (TDM) of vancomycin. OBJECTI...

    Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis. Last updated: 2016

    This guideline covers assessing and diagnosing recent chest pain in people aged 18 and over and managing symptoms while a diagnosis is being made. It aims to improve outcomes by providing advice on tests (ECG, high-sensitivity troponin tests, multislice CT angiography, functional testing) that support he...

    Jaundice in newborn babies under 28 days. Last updated: 2016

    This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated. In October 2016, recommendation 1.4.9 was amended to ...